Clinical ink
Winston-Salem, US · Founded 2013 · Delaware corporation · 3 known investors
Find your way into Clinical ink
Clinicalink offers a digital tool designed to improve drug adherence and measure the functional quality of weight loss. The product operates in the digital health space with clinical expertise spanning cardiology, rare disease, and oncology.
Founders & leadership
Clinical ink was founded in 2013 by Douglas E. Pierce, Jr..
DE
Douglas E. Pierce, Jr.Founder
JS
Joe SchmidtExecutive
ES
Edward S. SeguineExecutive
Board
AG
BG
Brad GeesamanBoard director
RK
Robert KniejskiBoard director
TF
MJ
Morana Jovan-EmbiricosBoard director
PR
Philip RS Waugh, Jr.Board director
Investors · 3
Reported raises · per SEC filings
Form D private placements$16.9M disclosed across 3 rounds · 2015–2018
▶$5.3MraisedMay 2018 · 5 investors · OtherRule 506(b)
▶$5.3MraisedMay 2018 · 5 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Matthew KingDirector
- Edward S. Seguine, Jr.Executive Officer, Director
- Richard MalcolmDirector
- Roger LaVern DavenportDirector
- Michael SorensenDirector
- Amount sold
- $5.3M
- Minimum investment
- $2.7K
- First sale
- May 2018
- Incorporated
- Corporation, Delaware, 2013
- Federal exemptions
- 06b
▶$1.7MraisedDec 2017 · 9 investors · OtherRule 506(b)
▶$1.7MraisedDec 2017 · 9 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Tony RosenbergDirector
- Phil WaughDirector
- Todd FoleyDirector
- Richard MalcolmDirector
- Scott MiltenbergerExecutive Officer
- Edward S. Seguine, Jr.Executive Officer, Director
- Matt KingDirector
- Offering amount
- $2.5M
- Amount sold
- $1.7M
- First sale
- Dec 2017
- Incorporated
- Corporation, Delaware, 2013
- Federal exemptions
- 06b
▶$9.9MraisedApr 2015 · 21 investors · OtherRule 506(b)
▶$9.9MraisedApr 2015 · 21 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Ansbert GadickeDirector
- Matt KingDirector
- Joe SchmidtExecutive Officer
- Brad GeesamanDirector
- Robert KniejskiDirector
- Todd FoleyDirector
- Morana Jovan-EmbiricosDirector
- Philip RS Waugh, Jr.Director
- Douglas E. Pierce, Jr.Executive Officer, Director, Promoter
- Edward S. SeguineExecutive Officer, Director, Promoter
- Offering amount
- $9.9M
- Amount sold
- $9.9M
- First sale
- Mar 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Founder mafia
2 people who came through Clinical ink went on to found or lead other companies.
Competitors · 6
by search overlap
IQVIA65 shared keywordsIQVIA is a healthcare data and technology company that supports life sciences organizations in research, clinical development, and commercialization of medicines and medical solutions.
Signant Health43 shared keywordsSignant Health provides software platforms and clinical trial solutions for life sciences companies to manage patient-reported outcomes, evidence generation, and digital endpoints in drug development programs across multiple therapeutic areas.
Medable41 shared keywordsMedable provides a cloud-based platform for clinical research that uses AI and digital tools to accelerate the development of therapies by improving the quality, reach, and efficiency of clinical trials. The platform serves pharmaceutical sponsors, contract research organizations (CROs), and clinical research sites.
Castor39 shared keywordsCastor provides a clinical trial data platform that combines electronic data capture, AI-assisted source data extraction with human review, and real-world evidence collection for medical device manufacturers, biopharma, diagnostics, and academic research teams. The platform connects siloed trial data and reduces manual data handling to accelerate the path from research to patient treatment.
Medidata35 shared keywordsMedidata is a clinical trial software platform that serves pharmaceutical, biotech, and healthcare organizations conducting clinical research. It provides end-to-end trial management, patient data analytics, and regulatory compliance solutions across thousands of trials and millions of patients globally.
Power33 shared keywordsPower builds a patient-friendly platform to discover and enroll in clinical trials, serving patients seeking access to research studies and researchers seeking to improve patient recruitment. The company operates in the healthcare technology and clinical research industry.
Companies competing with Clinical ink for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Clinical ink do?
- Clinicalink offers a digital tool designed to improve drug adherence and measure the functional quality of weight loss. The product operates in the digital health space with clinical expertise spanning cardiology, rare disease, and oncology.
- Who founded Clinical ink?
- Clinical ink was founded by Douglas E. Pierce, Jr. in 2013.
- Who are Clinical ink's investors?
- Clinical ink's investors include FCA Venture Partners, McKesson Ventures, MPM BioImpact.
- How much funding has Clinical ink raised?
- Clinical ink has disclosed $16.9M raised across 3 rounds.
- Where is Clinical ink headquartered?
- Clinical ink is headquartered in Winston-Salem, US.